Industry: Medical Devices & Consumables
Published Date: 2025-03-10
Pages: 97 Pages
Report ld: 4615536
Request Sample
Customized Report
The global market for Sutureless Aortic Biological Valve was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
North American market for Sutureless Aortic Biological Valve was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Sutureless Aortic Biological Valve was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Sutureless Aortic Biological Valve was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Sutureless Aortic Biological Valve include Edwards Lifesciences, LivaNova, Medtronic, Corcym, Braile Biomedica, Colibri Heart Valve, Jiecheng Medical Technology, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Sutureless Aortic Biological Valve, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Sutureless Aortic Biological Valve by region & country, by Type, and by Application.
The Sutureless Aortic Biological Valve market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sutureless Aortic Biological Valve.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Sutureless Aortic Biological Valve manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Sutureless Aortic Biological Valve in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Sutureless Aortic Biological Valve in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Sutureless Aortic Biological Valve Product Introduction
1.2 Global Sutureless Aortic Biological Valve Market Size Forecast
1.2.1 Global Sutureless Aortic Biological Valve Sales Value (2020-2031)
1.2.2 Global Sutureless Aortic Biological Valve Sales Volume (2020-2031)
1.2.3 Global Sutureless Aortic Biological Valve Sales Price (2020-2031)
1.3 Sutureless Aortic Biological Valve Market Trends & Drivers
1.3.1 Sutureless Aortic Biological Valve Industry Trends
1.3.2 Sutureless Aortic Biological Valve Market Drivers & Opportunity
1.3.3 Sutureless Aortic Biological Valve Market Challenges
1.3.4 Sutureless Aortic Biological Valve Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Sutureless Aortic Biological Valve Players Revenue Ranking (2024)
2.2 Global Sutureless Aortic Biological Valve Revenue by Company (2020-2025)
2.3 Global Sutureless Aortic Biological Valve Players Sales Volume Ranking (2024)
2.4 Global Sutureless Aortic Biological Valve Sales Volume by Company Players (2020-2025)
2.5 Global Sutureless Aortic Biological Valve Average Price by Company (2020-2025)
2.6 Key Manufacturers Sutureless Aortic Biological Valve Manufacturing Base and Headquarters
2.7 Key Manufacturers Sutureless Aortic Biological Valve Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Sutureless Aortic Biological Valve
2.9 Sutureless Aortic Biological Valve Market Competitive Analysis
2.9.1 Sutureless Aortic Biological Valve Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Sutureless Aortic Biological Valve Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sutureless Aortic Biological Valve as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Bovine Tissue
3.1.2 Porcine Tissue
3.2 Global Sutureless Aortic Biological Valve Sales Value by Type
3.2.1 Global Sutureless Aortic Biological Valve Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Sutureless Aortic Biological Valve Sales Value, by Type (2020-2031)
3.2.3 Global Sutureless Aortic Biological Valve Sales Value, by Type (%) (2020-2031)
3.3 Global Sutureless Aortic Biological Valve Sales Volume by Type
3.3.1 Global Sutureless Aortic Biological Valve Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Sutureless Aortic Biological Valve Sales Volume, by Type (2020-2031)
3.3.3 Global Sutureless Aortic Biological Valve Sales Volume, by Type (%) (2020-2031)
3.4 Global Sutureless Aortic Biological Valve Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Public Hospital
4.1.2 Private Hospital
4.2 Global Sutureless Aortic Biological Valve Sales Value by Application
4.2.1 Global Sutureless Aortic Biological Valve Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Sutureless Aortic Biological Valve Sales Value, by Application (2020-2031)
4.2.3 Global Sutureless Aortic Biological Valve Sales Value, by Application (%) (2020-2031)
4.3 Global Sutureless Aortic Biological Valve Sales Volume by Application
4.3.1 Global Sutureless Aortic Biological Valve Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Sutureless Aortic Biological Valve Sales Volume, by Application (2020-2031)
4.3.3 Global Sutureless Aortic Biological Valve Sales Volume, by Application (%) (2020-2031)
4.4 Global Sutureless Aortic Biological Valve Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Sutureless Aortic Biological Valve Sales Value by Region
5.1.1 Global Sutureless Aortic Biological Valve Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Sutureless Aortic Biological Valve Sales Value by Region (2020-2025)
5.1.3 Global Sutureless Aortic Biological Valve Sales Value by Region (2026-2031)
5.1.4 Global Sutureless Aortic Biological Valve Sales Value by Region (%), (2020-2031)
5.2 Global Sutureless Aortic Biological Valve Sales Volume by Region
5.2.1 Global Sutureless Aortic Biological Valve Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Sutureless Aortic Biological Valve Sales Volume by Region (2020-2025)
5.2.3 Global Sutureless Aortic Biological Valve Sales Volume by Region (2026-2031)
5.2.4 Global Sutureless Aortic Biological Valve Sales Volume by Region (%), (2020-2031)
5.3 Global Sutureless Aortic Biological Valve Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Sutureless Aortic Biological Valve Sales Value, 2020-2031
5.4.2 North America Sutureless Aortic Biological Valve Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Sutureless Aortic Biological Valve Sales Value, 2020-2031
5.5.2 Europe Sutureless Aortic Biological Valve Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Sutureless Aortic Biological Valve Sales Value, 2020-2031
5.6.2 Asia Pacific Sutureless Aortic Biological Valve Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Sutureless Aortic Biological Valve Sales Value, 2020-2031
5.7.2 South America Sutureless Aortic Biological Valve Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Sutureless Aortic Biological Valve Sales Value, 2020-2031
5.8.2 Middle East & Africa Sutureless Aortic Biological Valve Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Sutureless Aortic Biological Valve Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Sutureless Aortic Biological Valve Sales Value and Sales Volume
6.2.1 Key Countries/Regions Sutureless Aortic Biological Valve Sales Value, 2020-2031
6.2.2 Key Countries/Regions Sutureless Aortic Biological Valve Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Sutureless Aortic Biological Valve Sales Value, 2020-2031
6.3.2 United States Sutureless Aortic Biological Valve Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Sutureless Aortic Biological Valve Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Sutureless Aortic Biological Valve Sales Value, 2020-2031
6.4.2 Europe Sutureless Aortic Biological Valve Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Sutureless Aortic Biological Valve Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Sutureless Aortic Biological Valve Sales Value, 2020-2031
6.5.2 China Sutureless Aortic Biological Valve Sales Value by Type (%), 2024 VS 2031
6.5.3 China Sutureless Aortic Biological Valve Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Sutureless Aortic Biological Valve Sales Value, 2020-2031
6.6.2 Japan Sutureless Aortic Biological Valve Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Sutureless Aortic Biological Valve Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Sutureless Aortic Biological Valve Sales Value, 2020-2031
6.7.2 South Korea Sutureless Aortic Biological Valve Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Sutureless Aortic Biological Valve Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Sutureless Aortic Biological Valve Sales Value, 2020-2031
6.8.2 Southeast Asia Sutureless Aortic Biological Valve Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Sutureless Aortic Biological Valve Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Sutureless Aortic Biological Valve Sales Value, 2020-2031
6.9.2 India Sutureless Aortic Biological Valve Sales Value by Type (%), 2024 VS 2031
6.9.3 India Sutureless Aortic Biological Valve Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Edwards Lifesciences
7.1.1 Edwards Lifesciences Company Information
7.1.2 Edwards Lifesciences Introduction and Business Overview
7.1.3 Edwards Lifesciences Sutureless Aortic Biological Valve Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Edwards Lifesciences Sutureless Aortic Biological Valve Product Offerings
7.1.5 Edwards Lifesciences Recent Development
7.2 LivaNova
7.2.1 LivaNova Company Information
7.2.2 LivaNova Introduction and Business Overview
7.2.3 LivaNova Sutureless Aortic Biological Valve Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 LivaNova Sutureless Aortic Biological Valve Product Offerings
7.2.5 LivaNova Recent Development
7.3 Medtronic
7.3.1 Medtronic Company Information
7.3.2 Medtronic Introduction and Business Overview
7.3.3 Medtronic Sutureless Aortic Biological Valve Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Medtronic Sutureless Aortic Biological Valve Product Offerings
7.3.5 Medtronic Recent Development
7.4 Corcym
7.4.1 Corcym Company Information
7.4.2 Corcym Introduction and Business Overview
7.4.3 Corcym Sutureless Aortic Biological Valve Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Corcym Sutureless Aortic Biological Valve Product Offerings
7.4.5 Corcym Recent Development
7.5 Braile Biomedica
7.5.1 Braile Biomedica Company Information
7.5.2 Braile Biomedica Introduction and Business Overview
7.5.3 Braile Biomedica Sutureless Aortic Biological Valve Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Braile Biomedica Sutureless Aortic Biological Valve Product Offerings
7.5.5 Braile Biomedica Recent Development
7.6 Colibri Heart Valve
7.6.1 Colibri Heart Valve Company Information
7.6.2 Colibri Heart Valve Introduction and Business Overview
7.6.3 Colibri Heart Valve Sutureless Aortic Biological Valve Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Colibri Heart Valve Sutureless Aortic Biological Valve Product Offerings
7.6.5 Colibri Heart Valve Recent Development
7.7 Jiecheng Medical Technology
7.7.1 Jiecheng Medical Technology Company Information
7.7.2 Jiecheng Medical Technology Introduction and Business Overview
7.7.3 Jiecheng Medical Technology Sutureless Aortic Biological Valve Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Jiecheng Medical Technology Sutureless Aortic Biological Valve Product Offerings
7.7.5 Jiecheng Medical Technology Recent Development
8 Industry Chain Analysis
8.1 Sutureless Aortic Biological Valve Industrial Chain
8.2 Sutureless Aortic Biological Valve Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Sutureless Aortic Biological Valve Sales Model
8.5.2 Sales Channel
8.5.3 Sutureless Aortic Biological Valve Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Sutureless Aortic Biological Valve market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-27
Pages: 142
USD 4900.00
(Single User License)
The global Sutureless Aortic Biological Valve market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-27
Pages: 76
USD 4250.00
(Single User License)
The global market for Sutureless Aortic Biological Valve was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 104
USD 3950.00
(Single User License)
The global Sutureless Aortic Biological Valve market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-15
Pages: 114
USD 2900.00
(Single User License)
The global Sutureless Aortic Biological Valve market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 146
USD 4900.00
(Single User License)
The global Sutureless Aortic Biological Valve market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 80
USD 4250.00
(Single User License)
The global market for Sutureless Aortic Biological Valve was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 86
USD 2900.00
(Single User License)
The global Sutureless Aortic Biological Valve revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-06-07
Pages: 107
USD 4350.00
(Single User License)
The global Sutureless Aortic Biological Valve market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-06-07
Pages: 130
USD 4900.00
(Single User License)
The global market for Sutureless Aortic Biological Valve was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-06-07
Pages: 108
USD 3950.00
(Single User License)
The global Sutureless Aortic Biological Valve market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-27
Pages: 142
The global Sutureless Aortic Biological Valve market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-27
Pages: 76
The global market for Sutureless Aortic Biological Valve was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 104
The global Sutureless Aortic Biological Valve market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 114
The global Sutureless Aortic Biological Valve market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 146
The global Sutureless Aortic Biological Valve market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 80
The global market for Sutureless Aortic Biological Valve was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 86
The global Sutureless Aortic Biological Valve revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-06-07
Pages: 107
The global Sutureless Aortic Biological Valve market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-06-07
Pages: 130
The global market for Sutureless Aortic Biological Valve was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published: 2024-06-07
Pages: 108
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now